Search
TC-6987
go.drugbank.com/drugs/DB14854InvestigationalTC-6987 is under investigation in clinical trial NCT01296087 (TC-6987 for the Treatment of Mild to Moderate Asthma).
Abrilumab
go.drugbank.com/drugs/DB15076InvestigationalAbrilumab is under investigation in clinical trial NCT01290042 (Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.).
MOL-4239
go.drugbank.com/drugs/DB16051InvestigationalMOL-4239 is under investigation in clinical trial NCT01826201 (Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis).
BB-1701
go.drugbank.com/drugs/DB17443InvestigationalBB-1701 is a humanized IgG1 kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulin developed by Bliss Biopharmaceutical.
Synonyms: Humanized IgG1kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulinCEQ508
go.drugbank.com/drugs/DB17911ExperimentalColi Expressing Beta Catenin ShRNA currently being investigated to treat Familial Adenomatous Polyposis.
Clesacostat
go.drugbank.com/drugs/DB18956InvestigationalClesacostat is under investigation in clinical trial NCT04321031 (Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)).
Efzofitimod
go.drugbank.com/drugs/DB16453InvestigationalEfzofitimod (ATYR1923) is a fusion protein comprised of the immuno-modulatory domain of histidyl tRNA synthetase fused to the FC region of a human antibody.
Spermine
go.drugbank.com/drugs/DB00127InvestigationalNutraceuticalSpermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.
Prezatide copper
go.drugbank.com/drugs/DB14683InvestigationalIt is known to aid wound healing and its potential applications in chronic obstructive pulmonary disease and metastatic colon cancer are currently being investigated.
Etiracetam
go.drugbank.com/drugs/DB11868ExperimentalEtiracetam is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).